tuxobertinib
N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7-(2-morpholin-4-ylethoxy)quinazolin-6-yl]prop-2-enamide
Molecular Identity
tuxobertinib
N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7-(2-morpholin-4-ylethoxy)quinazolin-6-yl]prop-2-enamide
PubChem CID: 154824631
2D Structure
Properties
C29H29ClN6O4
Molecular Formula
561.00
Molecular Weight
g/mol
560.1939
Exact Mass
Da
3.9
XLogP
Drug-like (Lipinski: < 5)
111
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
9
H-Bond Acceptors
804
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
tuxobertinibBDTX-1892414572-47-5BDTX189Tuxobertinib [INN]N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7-(2-morpholin-4-ylethoxy)quinazolin-6-yl]prop-2-enamide6CE2107J4Texample 8 [US11034672B1]example 8 (US11034672B1)N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)anilino)-7-(2-morpholin-4-ylethoxy)quinazolin-6-yl)prop-2-enamideRefChem:192607BDTX 189BDTX-189 [WHO-DD]EGFR/HER2 Inhibitor BDTX-189Allosteric ErbB Inhibitor BDTX-189
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to tuxobertinib
Loading drug network...